Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) EBITDA (2016 - 2023)

Historic EBITDA for Aethlon Medical (AEMD) over the last 13 years, with Q1 2023 value amounting to -$2.5 million.

  • Aethlon Medical's EBITDA rose 3454.55% to -$2.5 million in Q1 2023 from the same period last year, while for Mar 2023 it was -$11.9 million, marking a year-over-year decrease of 1418.46%. This contributed to the annual value of -$13.4 million for FY2025, which is 974.13% down from last year.
  • Latest data reveals that Aethlon Medical reported EBITDA of -$2.5 million as of Q1 2023, which was up 3454.55% from -$2.8 million recorded in Q4 2022.
  • Over the past 5 years, Aethlon Medical's EBITDA peaked at -$876406.0 during Q4 2019, and registered a low of -$3.8 million during Q1 2022.
  • Moreover, its 5-year median value for EBITDA was -$2.1 million (2021), whereas its average is -$2.2 million.
  • Per our database at Business Quant, Aethlon Medical's EBITDA surged by 5537.36% in 2019 and then crashed by 17891.07% in 2020.
  • Quarter analysis of 5 years shows Aethlon Medical's EBITDA stood at -$876406.0 in 2019, then crashed by 178.91% to -$2.4 million in 2020, then dropped by 3.42% to -$2.5 million in 2021, then dropped by 12.73% to -$2.8 million in 2022, then grew by 13.05% to -$2.5 million in 2023.
  • Its EBITDA was -$2.5 million in Q1 2023, compared to -$2.8 million in Q4 2022 and -$3.7 million in Q3 2022.